Edition:
Deutschland

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

83.18EUR
23 May 2018
Change (% chg)

€-1.30 (-1.54%)
Prev Close
€84.48
Open
€84.14
Day's High
€84.32
Day's Low
€82.50
Volume
636,342
Avg. Vol
635,364
52-wk High
€112.65
52-wk Low
€74.54

MRCG.DE

Chart for MRCG.DE

About

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company operates through four business segments: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnol... (more)

Buy/Sell

Sell Hold Buy
2.18 Mean rating from 28 analysts

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

German stocks - Factors to watch on May 17

BERLIN/FRANKFURT, May 17 The following are some of the factors that may move German stocks on Thursday:

Merck KGaA's lung cancer drugs show promise in early-stage trials

FRANKFURT, May 16 Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping the company's efforts to find drug-industry partners to share further development costs.

German stocks - Factors to watch on May 16

FRANKFURT, May 16 The following are some of the factors that may move German stocks on Wednesday:

Merck KGaA first quarter earnings down on liquid crystals, currencies

FRANKFURT Germany's Merck KGaA saw earnings decline in the first quarter and predicted a drop for the full year, hurt by Chinese competition in liquid crystals used in flat screens and a strong euro weighing on the value of overseas sales.

UPDATE 1-Merck KGaA Q1 earnings down on liquid crystals, currencies

* Strong euro to cause 5-7 percent drag on 2018 EBITDA (Adds detailed guidance, forex effects)

Merck KGaA Q1 earnings down on liquid crystals, currencies

FRANKFURT, May 15 Germany's Merck KGaA saw earnings decline in the first quarter, hurt by Chinese competition in liquid crystals used in flat screens and a strong euro weighing on the value of overseas sales.

German stocks - Factors to watch on May 15

BERLIN/FRANKFURT, May 15 The following are some of the factors that may move German stocks on Tuesday:

UPDATE 1-Setback to Roche hopes for Tecentriq as fails key cancer trial

* Exelixis shares indicated 9.4 pct lower (Adds details about Exelixis, enrollment halt after patient deaths, Exelixis pre-market share price drop)

Setback to Roche hopes for Tecentriq as fails key cancer trial

ZURICH, May 10 Roche's hopes of its Tecentriq immunotherapy catching up rival medicines from Merck and Bristol-Myers Squibb were dealt a blow on Thursday after it failed a key combination trial.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -1.01%
Rohstoffe -0.41%
Industrie -0.14%
Konjunktur abhängige Waren & Dienstleistungen +0.32%
Konjunktur unabhängige Waren & Dienstleistungen -0.57%
Finanzindustrie +0.11%
Pharma +0.74%
Technologie -0.31%
Telekommunikation +0.41%

Nachrichten aus der Wirtschaft

Photo

US-Industrie mit weniger Aufträgen

Washington Überraschend starker Auftragsschwund in der US-Industrie: Die Bestellungen für langlebige Güter - vom Toaster bis zum Flugzeug - fielen im April um 1,7 Prozent zum Vormonat, wie das Handelsministerium am Freitag in Washington mitteilte.